Welcome to Tyner Law Firm.com  

About the Firm
Areas of Practice
Contact us
Community Service
Instant Case Analysis
Legal Links
TLF News

 

 


Submit Baycol Claim

Click Here


Baycol

(Cerivastatin Sodium Tablets)

 

History and Background

Baycol is a prescription drug produced by Bayer and GlaxoSmithKline.  It was designed to lower cholesterol and triglicerides in the bloodstream. Baycol is a “statin” drug, and like drugs of this group, it inhibits the enzyme HMG-CoA reductase.  With this enzyme inhibited, cholesterol production in the body is reduced.  However, Baycol has been shown to cause liver and kidney damage, liver failure, and muscle degeneration in patients, thus making the treatment far worse than the ailment.

Bayer seems to have never had a moments rest in dealing with the problems associated with Baycol.  In December of 1999, the Bayer Corporation changed the Baycol prescribing information to include additional contraindicated drugs.  Additionally, health care professionals were instructed to never combine Baycol with gemfibrozil under any circumstances. 

On May 21, 2001 the Food and Drug Administration issued a letter to Healthcare Professionals informing them of Bayer’s voluntary change in the prescribing information concerning Baycol.  They indicated that dosages should be lowered and issued additional warnings reinforcing the risks associated with myopathy and rhabdomyolysis.

 

Baycol was recalled by Bayer on August 8, 2001.  The recall was due to the harmful side effects that have been attributed to Baycol and the extreme risk that Baycol has to patient safety.

 

 

Legal Issues Surrounding Baycol

The FDA ordered GlaxoSmithKline and Bayer, the manufacturer of Rezulin, to put stronger liver toxicity warnings on the drug and an advisory committee recommended the drug be available to only a select group of patients due to the immense risk of harm.  Additionally, Baycol causes the condition known as rhabdomyolysis, a disorder involving injury to the kidneys caused by toxic effects of the contents of muscle cells. Baycol is also responsible for a condition called myglobinuria, which occurs when myoglobins, a tissue associated with muscle cells, is present in the urine.  These conditions are extremely harmful and require medical treatment.  Additionally, Baycol could have avoided these risks through proper diligence and testing.  The warnings, as well as the eventual removal from the market comes too late for those who have taken the drug and have experienced the debilitating side effects of Baycol.

 

Side Effects and Signals

Ø      Joint pain

Ø      Sinus problems

Ø      Weakness

Ø      Muscle pain

Ø      Increased cough

Ø      Insomnia

Ø      Low blood pressure

Ø      Unusual tiredness

Ø      Kidney damage

Ø      Malaise

Ø      Red tint in urine

Ø      Seizures

Ø      Blood infection

Ø      Dark urine

Ø      Unexplained weight gain

Ø      Decreased muscle mass

Ø      Kidney Failure

Ø       Liver Failure

Submit Baycol Claim

Click Here

 

 

 

   
 

All rights reserved. All Content is © Tyner Law Firm, P.A.
Best viewed at 800x600 resolution with 16bit color